doxorubicin hydrochloride Cayman Chemical Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Cayman Chemical doxorubicin hydrochloride
    SP-2509 but not GSK-LSD1 significantly reduces the proliferative capacity of Ewing sarcoma cell lines (A) SP-2509 hypersensitive (A673, TC252) and sensitive (ES-2) Ewing sarcoma cell lines treated with the indicated concentrations of SP-2509, GSK-LSD1, <t>Doxorubicin</t> or vehicle control (DMSO) for 96hrs. Proliferative capacity and induction of apoptosis (caspase 3/7 activity) was measured in real-time through IncuCyte ZOOM live cell imaging. Data represents mean ± SEM confluency or green object count, from three independent experiments. (B) Statistical analysis of proliferation or caspase 3/7 induction compared to vehicle control cells (ns: not significant). (C) Representative phase contrast and green fluorescence (caspase 3/7) images following 72hrs of treatment with the indicated agents.
    Doxorubicin Hydrochloride, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/doxorubicin hydrochloride/product/Cayman Chemical
    Average 93 stars, based on 26 article reviews
    Price from $9.99 to $1999.99
    doxorubicin hydrochloride - by Bioz Stars, 2020-02
    93/100 stars
      Buy from Supplier

    78
    Cayman Chemical doxorubicin hydrochloride dox hcl
    Light templated <t>doxorubicin</t> delivery in vitro. Patterned light (365 nm, 15–17 mW/cm 2 ) activation of 1 (300 μM) and cellular uptake of DOX ( red ).
    Doxorubicin Hydrochloride Dox Hcl, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 78/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/doxorubicin hydrochloride dox hcl/product/Cayman Chemical
    Average 78 stars, based on 5 article reviews
    Price from $9.99 to $1999.99
    doxorubicin hydrochloride dox hcl - by Bioz Stars, 2020-02
    78/100 stars
      Buy from Supplier

    96
    LC Laboratories doxorubicin
    Light templated <t>doxorubicin</t> delivery in vitro. Patterned light (365 nm, 15–17 mW/cm 2 ) activation of 1 (300 μM) and cellular uptake of DOX ( red ).
    Doxorubicin, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 245 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/doxorubicin/product/LC Laboratories
    Average 96 stars, based on 245 article reviews
    Price from $9.99 to $1999.99
    doxorubicin - by Bioz Stars, 2020-02
    96/100 stars
      Buy from Supplier

    78
    Millipore chemodrug doxorubicin
    Blocking Src's metabolic effect sensitizes cancer cells to pro-oxidant chemotherapy A, B. Src inhibitors and <t>chemodrug</t> <t>Doxorubicin</t> (Dox) show additive/synergistic effects on ROS induction and suppression of cell growth/viability. 4T1 cells were treated with Dox (1 μg/ml) and Src inhibitors SA and SU (1 μM each). ROS levels (A) and cell growth and viability (B) were subsequently determined. C, D. Expression of PDHA1 Y289F sensitizes cells to pro-oxidant. 4T1 cells transduced with WT or Y289F PDHA1 were treated with vehicle (DMSO) or Dox, followed by measurement of ROS levels (C) and cell growth and survival (D). Error bars represent S.D. *p
    Chemodrug Doxorubicin, supplied by Millipore, used in various techniques. Bioz Stars score: 78/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chemodrug doxorubicin/product/Millipore
    Average 78 stars, based on 4 article reviews
    Price from $9.99 to $1999.99
    chemodrug doxorubicin - by Bioz Stars, 2020-02
    78/100 stars
      Buy from Supplier

    77
    Cayman Chemical cytotoxic agent doxorubicin
    Blocking Src's metabolic effect sensitizes cancer cells to pro-oxidant chemotherapy A, B. Src inhibitors and <t>chemodrug</t> <t>Doxorubicin</t> (Dox) show additive/synergistic effects on ROS induction and suppression of cell growth/viability. 4T1 cells were treated with Dox (1 μg/ml) and Src inhibitors SA and SU (1 μM each). ROS levels (A) and cell growth and viability (B) were subsequently determined. C, D. Expression of PDHA1 Y289F sensitizes cells to pro-oxidant. 4T1 cells transduced with WT or Y289F PDHA1 were treated with vehicle (DMSO) or Dox, followed by measurement of ROS levels (C) and cell growth and survival (D). Error bars represent S.D. *p
    Cytotoxic Agent Doxorubicin, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 77/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cytotoxic agent doxorubicin/product/Cayman Chemical
    Average 77 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    cytotoxic agent doxorubicin - by Bioz Stars, 2020-02
    77/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology doxorubicin
    Pharmacological or genetic inhibition of DNM1L blocks mitochondrial fission and apoptosis induced by liensinine in combination with <t>doxorubicin.</t> ( A ) MDA-MB-231 cells were co-exposed to Lien (20 μM) and Dox (0.2 μM) in the presence or absence
    Doxorubicin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 82 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/doxorubicin/product/Santa Cruz Biotechnology
    Average 96 stars, based on 82 article reviews
    Price from $9.99 to $1999.99
    doxorubicin - by Bioz Stars, 2020-02
    96/100 stars
      Buy from Supplier

    91
    Cayman Chemical epirubicin
    Pharmacological or genetic inhibition of DNM1L blocks mitochondrial fission and apoptosis induced by liensinine in combination with <t>doxorubicin.</t> ( A ) MDA-MB-231 cells were co-exposed to Lien (20 μM) and Dox (0.2 μM) in the presence or absence
    Epirubicin, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 91/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/epirubicin/product/Cayman Chemical
    Average 91 stars, based on 7 article reviews
    Price from $9.99 to $1999.99
    epirubicin - by Bioz Stars, 2020-02
    91/100 stars
      Buy from Supplier

    Image Search Results


    SP-2509 but not GSK-LSD1 significantly reduces the proliferative capacity of Ewing sarcoma cell lines (A) SP-2509 hypersensitive (A673, TC252) and sensitive (ES-2) Ewing sarcoma cell lines treated with the indicated concentrations of SP-2509, GSK-LSD1, Doxorubicin or vehicle control (DMSO) for 96hrs. Proliferative capacity and induction of apoptosis (caspase 3/7 activity) was measured in real-time through IncuCyte ZOOM live cell imaging. Data represents mean ± SEM confluency or green object count, from three independent experiments. (B) Statistical analysis of proliferation or caspase 3/7 induction compared to vehicle control cells (ns: not significant). (C) Representative phase contrast and green fluorescence (caspase 3/7) images following 72hrs of treatment with the indicated agents.

    Journal: Molecular cancer therapeutics

    Article Title: Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma with SP-2509 engages the endoplasmic reticulum stress response

    doi: 10.1158/1535-7163.MCT-18-0373

    Figure Lengend Snippet: SP-2509 but not GSK-LSD1 significantly reduces the proliferative capacity of Ewing sarcoma cell lines (A) SP-2509 hypersensitive (A673, TC252) and sensitive (ES-2) Ewing sarcoma cell lines treated with the indicated concentrations of SP-2509, GSK-LSD1, Doxorubicin or vehicle control (DMSO) for 96hrs. Proliferative capacity and induction of apoptosis (caspase 3/7 activity) was measured in real-time through IncuCyte ZOOM live cell imaging. Data represents mean ± SEM confluency or green object count, from three independent experiments. (B) Statistical analysis of proliferation or caspase 3/7 induction compared to vehicle control cells (ns: not significant). (C) Representative phase contrast and green fluorescence (caspase 3/7) images following 72hrs of treatment with the indicated agents.

    Article Snippet: SP-2509 was provided by Dr Sunil Sharma (TGen Clinical Sciences), Doxorubicin hydrochloride and GSK-LSD1 ( ) were purchased from Cayman Chemical, Thapsigargin and AraC (Cytosine Arabinoside) were sourced from Sigma-Aldrich.

    Techniques: Activity Assay, Live Cell Imaging, Fluorescence

    WDR23 overexpression enhances chemotherapy toxicity. ( A-C ) Cells overexpressing GFP:WDR23 isoform 1 (pink) or GFP:WDR23 isoform 2 (orange) are more sensitive to increasing concentrations of ( A ) etoposide (25uM n = 12 each, 50um n = 8 each, 75um n = 8 each), ( B ) doxorubicin (1uM n = 12 each, 2uM n = 8 each), or ( C ) cisplatin (50uM n = 12 each, 75uM n = 8 each, 100uM n = 8 each) as compared to cells expressing GFP alone (black). ( D,E ) The percentage of cells carrying DNA double strand breaks (DSB), as indicated by dual phospho-H2Ax and phospho-ATM staining, is increased when WDR23 isoform 1 or WDR23 isoform 2 is overexpressed (Control n = 3, Iso 1 n = 3, Iso 2 n = 3) and ( E ) enhances DSB incidence following etoposide treatment (Control n = 3, Iso 1 n = 3, Iso 2 n = 3). ( F ) Cellular apoptosis (Annexin V positive) is increased in cells overexpressing WDR23 isoform 1 or WDR23 isoform 2 as compared to control cells overexpressing GFP alone (Control n = 3, Iso 1 n = 3, Iso 2 n = 3). Data are mean ± s.e.m.; one-tailed t -test relative to control GFP overexpression for each treatment condition. * P

    Journal: PLoS Genetics

    Article Title: WDR23 regulates NRF2 independently of KEAP1

    doi: 10.1371/journal.pgen.1006762

    Figure Lengend Snippet: WDR23 overexpression enhances chemotherapy toxicity. ( A-C ) Cells overexpressing GFP:WDR23 isoform 1 (pink) or GFP:WDR23 isoform 2 (orange) are more sensitive to increasing concentrations of ( A ) etoposide (25uM n = 12 each, 50um n = 8 each, 75um n = 8 each), ( B ) doxorubicin (1uM n = 12 each, 2uM n = 8 each), or ( C ) cisplatin (50uM n = 12 each, 75uM n = 8 each, 100uM n = 8 each) as compared to cells expressing GFP alone (black). ( D,E ) The percentage of cells carrying DNA double strand breaks (DSB), as indicated by dual phospho-H2Ax and phospho-ATM staining, is increased when WDR23 isoform 1 or WDR23 isoform 2 is overexpressed (Control n = 3, Iso 1 n = 3, Iso 2 n = 3) and ( E ) enhances DSB incidence following etoposide treatment (Control n = 3, Iso 1 n = 3, Iso 2 n = 3). ( F ) Cellular apoptosis (Annexin V positive) is increased in cells overexpressing WDR23 isoform 1 or WDR23 isoform 2 as compared to control cells overexpressing GFP alone (Control n = 3, Iso 1 n = 3, Iso 2 n = 3). Data are mean ± s.e.m.; one-tailed t -test relative to control GFP overexpression for each treatment condition. * P

    Article Snippet: Forty-eight hours post-transfection, cells were treated with the indicated chemical: Etoposide (Cayman), Doxorubicin (Cayman), or Cisplatin (Cayman).

    Techniques: Over Expression, Expressing, Staining, One-tailed Test

    Light templated doxorubicin delivery in vitro. Patterned light (365 nm, 15–17 mW/cm 2 ) activation of 1 (300 μM) and cellular uptake of DOX ( red ).

    Journal: International Journal of Molecular Sciences

    Article Title: Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles

    doi: 10.3390/ijms18102033

    Figure Lengend Snippet: Light templated doxorubicin delivery in vitro. Patterned light (365 nm, 15–17 mW/cm 2 ) activation of 1 (300 μM) and cellular uptake of DOX ( red ).

    Article Snippet: Materials and Instruments Doxorubicin hydrochloride (DOX·HCl) was purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and used without further purification.

    Techniques: In Vitro, Activation Assay

    Viability of HeLa cells in vitro treated with doxorubicin pro-drug micelles. ( a ) Cell viability following incubation with varying concentrations (10 nM–100 μM) of free DOX ( black ) and 1 ( red ) in the absence of light; ( b ) Viability of HeLa cells in vitro treated with varying concentrations of 1 and irradiated (365 nm, 15–17 mW/cm 2 ) for up to 1h. Pink line corresponds to photoinduced cytotoxicity.

    Journal: International Journal of Molecular Sciences

    Article Title: Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles

    doi: 10.3390/ijms18102033

    Figure Lengend Snippet: Viability of HeLa cells in vitro treated with doxorubicin pro-drug micelles. ( a ) Cell viability following incubation with varying concentrations (10 nM–100 μM) of free DOX ( black ) and 1 ( red ) in the absence of light; ( b ) Viability of HeLa cells in vitro treated with varying concentrations of 1 and irradiated (365 nm, 15–17 mW/cm 2 ) for up to 1h. Pink line corresponds to photoinduced cytotoxicity.

    Article Snippet: Materials and Instruments Doxorubicin hydrochloride (DOX·HCl) was purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and used without further purification.

    Techniques: In Vitro, Incubation, Irradiation

    Characterization of doxorubicin pro-drug micelles and light induced drug release. ( a ) TEM (transmission electron microscopy) image (uranyl acetate stain) of micelles of 1 (300 μM, approx. 0.7 mg/mL); ( b ) Time evolution of the HPLC (high-performance liquid chromatography) spectra of a solution of 1 (100 μM in PBS (phosphate buffered saline)) during photolysis (365 nm, 3–5 mW/cm 2 ). Free DOX (100 μM), dissolved in PBS, was used to confirm clean photolysis of 1 to release “active” DOX. HPLC conditions described in Materials and Methods; ( c ) CMC (critical micelle concentration) determination by light scattering following serial dilution of 1 (100 μM–75 nM) in PBS; ( d ) In vitro DOX release profiles from 1 (300 μM) in PBS. No UV irradiation ( red ), UV irradiation at 9 h ( black ) and free DOX control ( blue ).

    Journal: International Journal of Molecular Sciences

    Article Title: Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles

    doi: 10.3390/ijms18102033

    Figure Lengend Snippet: Characterization of doxorubicin pro-drug micelles and light induced drug release. ( a ) TEM (transmission electron microscopy) image (uranyl acetate stain) of micelles of 1 (300 μM, approx. 0.7 mg/mL); ( b ) Time evolution of the HPLC (high-performance liquid chromatography) spectra of a solution of 1 (100 μM in PBS (phosphate buffered saline)) during photolysis (365 nm, 3–5 mW/cm 2 ). Free DOX (100 μM), dissolved in PBS, was used to confirm clean photolysis of 1 to release “active” DOX. HPLC conditions described in Materials and Methods; ( c ) CMC (critical micelle concentration) determination by light scattering following serial dilution of 1 (100 μM–75 nM) in PBS; ( d ) In vitro DOX release profiles from 1 (300 μM) in PBS. No UV irradiation ( red ), UV irradiation at 9 h ( black ) and free DOX control ( blue ).

    Article Snippet: Materials and Instruments Doxorubicin hydrochloride (DOX·HCl) was purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and used without further purification.

    Techniques: Transmission Electron Microscopy, Transmission Assay, Electron Microscopy, Staining, High Performance Liquid Chromatography, Concentration Assay, Serial Dilution, In Vitro, Irradiation

    Light activated doxorubicin pro-drug micelles. ( a ) Doxorubicin- ortho -nitrobenzyl-mPEG 2000 construct, 1 ; ( b ) Self-assembly of 1 in aqueous media to 100 nm PEGylated and DOX (doxorubicin)-rich micelles from which quantitative drug release is triggered by light; ( c ) Light directed DOX release, cell uptake, and cell death.

    Journal: International Journal of Molecular Sciences

    Article Title: Spatiotemporal Control of Doxorubicin Delivery from “Stealth-Like” Prodrug Micelles

    doi: 10.3390/ijms18102033

    Figure Lengend Snippet: Light activated doxorubicin pro-drug micelles. ( a ) Doxorubicin- ortho -nitrobenzyl-mPEG 2000 construct, 1 ; ( b ) Self-assembly of 1 in aqueous media to 100 nm PEGylated and DOX (doxorubicin)-rich micelles from which quantitative drug release is triggered by light; ( c ) Light directed DOX release, cell uptake, and cell death.

    Article Snippet: Materials and Instruments Doxorubicin hydrochloride (DOX·HCl) was purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and used without further purification.

    Techniques: Construct

    Blocking Src's metabolic effect sensitizes cancer cells to pro-oxidant chemotherapy A, B. Src inhibitors and chemodrug Doxorubicin (Dox) show additive/synergistic effects on ROS induction and suppression of cell growth/viability. 4T1 cells were treated with Dox (1 μg/ml) and Src inhibitors SA and SU (1 μM each). ROS levels (A) and cell growth and viability (B) were subsequently determined. C, D. Expression of PDHA1 Y289F sensitizes cells to pro-oxidant. 4T1 cells transduced with WT or Y289F PDHA1 were treated with vehicle (DMSO) or Dox, followed by measurement of ROS levels (C) and cell growth and survival (D). Error bars represent S.D. *p

    Journal: Oncotarget

    Article Title: Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation

    doi: 10.18632/oncotarget.7159

    Figure Lengend Snippet: Blocking Src's metabolic effect sensitizes cancer cells to pro-oxidant chemotherapy A, B. Src inhibitors and chemodrug Doxorubicin (Dox) show additive/synergistic effects on ROS induction and suppression of cell growth/viability. 4T1 cells were treated with Dox (1 μg/ml) and Src inhibitors SA and SU (1 μM each). ROS levels (A) and cell growth and viability (B) were subsequently determined. C, D. Expression of PDHA1 Y289F sensitizes cells to pro-oxidant. 4T1 cells transduced with WT or Y289F PDHA1 were treated with vehicle (DMSO) or Dox, followed by measurement of ROS levels (C) and cell growth and survival (D). Error bars represent S.D. *p

    Article Snippet: Src inhibitors PP2, SU6656 and Saracatinib were purchased from Cayman Chemical, and chemodrug Doxorubicin from Sigma.

    Techniques: Blocking Assay, Expressing, Transduction

    Pharmacological or genetic inhibition of DNM1L blocks mitochondrial fission and apoptosis induced by liensinine in combination with doxorubicin. ( A ) MDA-MB-231 cells were co-exposed to Lien (20 μM) and Dox (0.2 μM) in the presence or absence

    Journal: Autophagy

    Article Title: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

    doi: 10.1080/15548627.2015.1056970

    Figure Lengend Snippet: Pharmacological or genetic inhibition of DNM1L blocks mitochondrial fission and apoptosis induced by liensinine in combination with doxorubicin. ( A ) MDA-MB-231 cells were co-exposed to Lien (20 μM) and Dox (0.2 μM) in the presence or absence

    Article Snippet: Liensinine (2586–96–1) was purchased from MUST bio-technology, 3-methyladenine (M9281), rapamycin (R117), acridine orange (158550), chloroquine diphosphate salt (C6628), Thiazolyl Blue Tetrazolium Blue (MTT, M2128), paclitaxel (T7191), vincristine (V8879) and cisplatin (P4394) were purchased from Sigma-Aldrich, bafilomycin A1 (11038) was purchased from Cayman Chemical, doxorubicin (sc-200923) and staurosporine (sc-360258) were purchased from Santa Cruz Biotechnology, and Mdivi-1 (s7162) was from Selleck Chemicals.

    Techniques: Polyacrylamide Gel Electrophoresis, Inhibition, Multiple Displacement Amplification

    The combination of liensinine and doxorubicin inhibits tumor growth in a MDA-MB-231 mouse xenograft model. ( A ) Average tumor volume in vehicle control mice, mice treated with Lien (60 mg/kg) or Dox (2 mg/kg) or a combination of Lien and

    Journal: Autophagy

    Article Title: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

    doi: 10.1080/15548627.2015.1056970

    Figure Lengend Snippet: The combination of liensinine and doxorubicin inhibits tumor growth in a MDA-MB-231 mouse xenograft model. ( A ) Average tumor volume in vehicle control mice, mice treated with Lien (60 mg/kg) or Dox (2 mg/kg) or a combination of Lien and

    Article Snippet: Liensinine (2586–96–1) was purchased from MUST bio-technology, 3-methyladenine (M9281), rapamycin (R117), acridine orange (158550), chloroquine diphosphate salt (C6628), Thiazolyl Blue Tetrazolium Blue (MTT, M2128), paclitaxel (T7191), vincristine (V8879) and cisplatin (P4394) were purchased from Sigma-Aldrich, bafilomycin A1 (11038) was purchased from Cayman Chemical, doxorubicin (sc-200923) and staurosporine (sc-360258) were purchased from Santa Cruz Biotechnology, and Mdivi-1 (s7162) was from Selleck Chemicals.

    Techniques: Multiple Displacement Amplification, Mouse Assay

    Excessive accumulation of autophagosomes/mitophagosomes mediated by combination of liensinine and doxorubicin in MDA-MB-231 cells. ( A ) Cells were treated with vehicle, Lien (20 μM), Dox (0.2 μM) alone or combined treated

    Journal: Autophagy

    Article Title: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

    doi: 10.1080/15548627.2015.1056970

    Figure Lengend Snippet: Excessive accumulation of autophagosomes/mitophagosomes mediated by combination of liensinine and doxorubicin in MDA-MB-231 cells. ( A ) Cells were treated with vehicle, Lien (20 μM), Dox (0.2 μM) alone or combined treated

    Article Snippet: Liensinine (2586–96–1) was purchased from MUST bio-technology, 3-methyladenine (M9281), rapamycin (R117), acridine orange (158550), chloroquine diphosphate salt (C6628), Thiazolyl Blue Tetrazolium Blue (MTT, M2128), paclitaxel (T7191), vincristine (V8879) and cisplatin (P4394) were purchased from Sigma-Aldrich, bafilomycin A1 (11038) was purchased from Cayman Chemical, doxorubicin (sc-200923) and staurosporine (sc-360258) were purchased from Santa Cruz Biotechnology, and Mdivi-1 (s7162) was from Selleck Chemicals.

    Techniques: Multiple Displacement Amplification

    Autophagic inhibition combined with doxorubicin induces mitochondrial fission via dephosphorylation and mitochondrial translocation of DNM1L. ( A and D ) MDA-MB-231 cells were treated with vehicle, Lien (20 μM), Dox (0.2 μM)

    Journal: Autophagy

    Article Title: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

    doi: 10.1080/15548627.2015.1056970

    Figure Lengend Snippet: Autophagic inhibition combined with doxorubicin induces mitochondrial fission via dephosphorylation and mitochondrial translocation of DNM1L. ( A and D ) MDA-MB-231 cells were treated with vehicle, Lien (20 μM), Dox (0.2 μM)

    Article Snippet: Liensinine (2586–96–1) was purchased from MUST bio-technology, 3-methyladenine (M9281), rapamycin (R117), acridine orange (158550), chloroquine diphosphate salt (C6628), Thiazolyl Blue Tetrazolium Blue (MTT, M2128), paclitaxel (T7191), vincristine (V8879) and cisplatin (P4394) were purchased from Sigma-Aldrich, bafilomycin A1 (11038) was purchased from Cayman Chemical, doxorubicin (sc-200923) and staurosporine (sc-360258) were purchased from Santa Cruz Biotechnology, and Mdivi-1 (s7162) was from Selleck Chemicals.

    Techniques: Inhibition, De-Phosphorylation Assay, Translocation Assay, Multiple Displacement Amplification

    Liensinine sensitizes to a variety of anticancer drug-induced cell death in MDA-MB-231 and MCF-7 cells. ( A ) MDA-MB-231 and MCF-7 cells were treated with various concentrations of doxorubicin (Dox), paclitaxel, vincristine, cisplatin (CDDP), and staurosporine

    Journal: Autophagy

    Article Title: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

    doi: 10.1080/15548627.2015.1056970

    Figure Lengend Snippet: Liensinine sensitizes to a variety of anticancer drug-induced cell death in MDA-MB-231 and MCF-7 cells. ( A ) MDA-MB-231 and MCF-7 cells were treated with various concentrations of doxorubicin (Dox), paclitaxel, vincristine, cisplatin (CDDP), and staurosporine

    Article Snippet: Liensinine (2586–96–1) was purchased from MUST bio-technology, 3-methyladenine (M9281), rapamycin (R117), acridine orange (158550), chloroquine diphosphate salt (C6628), Thiazolyl Blue Tetrazolium Blue (MTT, M2128), paclitaxel (T7191), vincristine (V8879) and cisplatin (P4394) were purchased from Sigma-Aldrich, bafilomycin A1 (11038) was purchased from Cayman Chemical, doxorubicin (sc-200923) and staurosporine (sc-360258) were purchased from Santa Cruz Biotechnology, and Mdivi-1 (s7162) was from Selleck Chemicals.

    Techniques: Multiple Displacement Amplification

    Autophagosome/mitophagosome accumulation contributed to the combination effect of liensinine and doxorubicin. MDA-MB-231 cells were co-exposed to Lien (20 μM) and Dox (0.2 μM) in the presence or absence of 3-MA (5 mM)

    Journal: Autophagy

    Article Title: A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission

    doi: 10.1080/15548627.2015.1056970

    Figure Lengend Snippet: Autophagosome/mitophagosome accumulation contributed to the combination effect of liensinine and doxorubicin. MDA-MB-231 cells were co-exposed to Lien (20 μM) and Dox (0.2 μM) in the presence or absence of 3-MA (5 mM)

    Article Snippet: Liensinine (2586–96–1) was purchased from MUST bio-technology, 3-methyladenine (M9281), rapamycin (R117), acridine orange (158550), chloroquine diphosphate salt (C6628), Thiazolyl Blue Tetrazolium Blue (MTT, M2128), paclitaxel (T7191), vincristine (V8879) and cisplatin (P4394) were purchased from Sigma-Aldrich, bafilomycin A1 (11038) was purchased from Cayman Chemical, doxorubicin (sc-200923) and staurosporine (sc-360258) were purchased from Santa Cruz Biotechnology, and Mdivi-1 (s7162) was from Selleck Chemicals.

    Techniques: Polyacrylamide Gel Electrophoresis, Multiple Displacement Amplification